v3.26.1
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2026
Sep. 30, 2025
Current Assets    
Cash $ 933,390
Prepaid expenses 81,353 30,900
Total Current Assets 1,014,743 30,900
Cash held in Trust Account 100,403,232
Deferred offering costs 82,594
Total Assets 101,417,975 113,494
Current Liabilities    
Accounts payable and accrued expenses 24,055 5,658
Accrued offering costs 75,350 57,594
Due to Sponsor 16,071
Promissory note – related party 41,320
Total Current Liabilities 115,476 104,572
Total Liabilities 115,476 104,572
Ordinary shares subject to possible redemption, 10,000,000 and 0 shares at a redemption value of $10.04 and 0 nil per share at March 31, 2026 and September 30, 2025, respectively. 100,403,232
Shareholders’ Equity    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 3,933,333 and 3,833,333 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively [1] 393 383
Additional paid-in capital 241,919 24,617
Retained earnings (Accumulated deficit) 656,955 (16,078)
Total Shareholders’ Equity 899,267 8,922
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity $ 101,417,975 $ 113,494
[1] The 3,833,333 Founder Shares as of September 30, 2025 includes up to 500,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On February 19, 2026, the underwriters elected to forfeit their over-allotment option to purchase up to an additional 1,500,000 Units, resulting in the forfeiture of the 500,000 Founder Shares (Note 5).